Chronic fatigue after SARS-CoV-2 infection

A recent study, published in Clinical Nutrition ESPEN journal, evaluated a nutritional supplement, supporting immune function and energy metabolism (Apportal®, Pharmanutra), on chronic fatigue associated with the SARS-CoV-2 post-infection progress.

Image Credit: PharmaNutra S.p.A.

Results of the study showed a significant improvement in quality of life and health status (Euro-QoL-5D questionnaire), chronic fatigue (FACIT-Fatigue questionnaire) and mental fatigue (modified Chalder questionnaire) both after 14 and 28 days of taking Apportal®. To date, this is the first study that demonstrates that taking a nutritional supplement can reduce chronic fatigue or improve the quality of life in people with post-Covid syndrome.

Last updated: Oct 5, 2021 at 5:04 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PharmaNutra Spa. (2021, October 05). Chronic fatigue after SARS-CoV-2 infection. News-Medical. Retrieved on October 23, 2021 from https://www.news-medical.net/whitepaper/20211004/Chronic-fatigue-after-SARS-CoV-2-infection.aspx.

  • MLA

    PharmaNutra Spa. "Chronic fatigue after SARS-CoV-2 infection". News-Medical. 23 October 2021. <https://www.news-medical.net/whitepaper/20211004/Chronic-fatigue-after-SARS-CoV-2-infection.aspx>.

  • Chicago

    PharmaNutra Spa. "Chronic fatigue after SARS-CoV-2 infection". News-Medical. https://www.news-medical.net/whitepaper/20211004/Chronic-fatigue-after-SARS-CoV-2-infection.aspx. (accessed October 23, 2021).

  • Harvard

    PharmaNutra Spa. 2021. Chronic fatigue after SARS-CoV-2 infection. News-Medical, viewed 23 October 2021, https://www.news-medical.net/whitepaper/20211004/Chronic-fatigue-after-SARS-CoV-2-infection.aspx.

Other White Papers by this Supplier